By Scientia Professor Anthony D Kelleher

Journal articles

Kaufmann GR; Zaunders J; Murray JM; Kelleher AD; Lewin S; Solomon A; Smith DE; Cooper DA, 2001, 'Relative significance of different pathways of immune reconstitution in HIV type 1 infection as estimated by mathematical modelling.', AIDS Research and Human Retroviruses, 17, pp. 147 - 159

Kelleher AD; Rowland-Jones SL, 2000, 'Functions of tetramer-stained HIV-specific CD4+ and CD8+ T cells', Current Opinion in Immunology, 12, pp. 370 - 374, http://dx.doi.org/10.1016/S0952-7915(00)00102-3

McMichael AJ; Ogg G; Wilson J; Callan M; Hambleton S; Appay V; Kelleher T; Rowland-Jones S, 2000, 'Memory CD8+ T cells in HIV infection', Philosophical Transactions of the Royal Society B Biological Sciences, 355, pp. 363 - 367, http://dx.doi.org/10.1098/rstb.2000.0575

Oxenius A; Price DA; Easterbrook PJ; O'Callaghan CA; Kelleher AD; Whelan JA; Sontag G; Sewell AK; Phillips RE, 2000, 'Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8⁺ and CD4⁺ T lymphocytes', PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 97, pp. 3382 - 3387, http://dx.doi.org/10.1073/pnas.97.7.3382

Sewell AK; Price DA; Oxenius A; Kelleher AD; Phillips RE, 2000, 'Cytotoxic T lymphocyte responses to human immunodeficiency virus: Control and escape', Stem Cells, 18, pp. 230 - 244, http://dx.doi.org/10.1634/stemcells.18-4-230

Price DA; Oxenius A; Easterbrook PJ; O'Callaghan CA; Kelleher A; Whelan JA; Sontag G; Sewell AK; Phillips RE, 2000, 'Highly active antiretroviral therapy for primary HIV-1 infection preserves immune function of virus-specific T lymphocytes', Quarterly Journal of Medicine, 93, pp. 769 - 769

Kaufmann GR; Zaunders J; Kelleher AD; Grey PA; Smith DE; Carr AD; Cooper DA, 2000, 'Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection', AIDS, 14, pp. 2543 - 2551

Benson EM; Clarkson J; Law M; Marshall P; Kelleher AD; Smith DE; Patou G; Stewart GJ; Cooper DA; Ffrench RA, 1999, 'Therapeutic vaccination with p24-VLP and zidovudine augments HIV- specific cytotoxic T lymphocyte activity in asymptomatic HIV-infected individuals', AIDS Research and Human Retroviruses, 15, pp. 105 - 113, http://dx.doi.org/10.1089/088922299311538

McMichael AJ; Kelleher A, 1999, 'The arrival of HLA class II tetramers', Journal of Clinical Investigation, 104, pp. 1669 - 1770, http://dx.doi.org/10.1172/jci8943

Kelleher AD; Sewell WA; Cooper DA, 1999, 'Effect of protease therapy on cytokine secretion by peripheral blood mononuclear cells (PBMC) from HIV-infected subjects', Clinical and Experimental Immunology, 115, pp. 147 - 152

Zaunders J; Cunningham PH; Kelleher AD; Kaufmann GR; Jaramillo AB; Wright RH; Smith DE; Grey PA; Vizzard J; Carr AD; Cooper DA, 1999, 'Potent antiretroviral therapy of primary HIV-1 infection: partial normalisation of T lympho-cyte subsets and limited reduction of proviral DNA despite clearance of plasma viremia.', Journal of Infectious Diseases, 180, pp. 320 - 329

Wilson JDK; Ogg GS; Allen RL; Goulder PJR; Kelleher A; Sewell AK; O'Callaghan CA; Rowland-Jones SL; Callan MFC; McMichael AJ, 1998, 'Oligoclonal expansions of CD8+ T cells in chronic HIV infection are antigen specific', Journal of Experimental Medicine, 188, pp. 785 - 790, http://dx.doi.org/10.1084/jem.188.4.785

Murray JM; Kaufmann GR; Kelleher AD; Cooper DA, 1998, 'A model of primary HIV-1 infection', Mathematical Biosciences, 154, pp. 57 - 85

Carr A; Kelleher A, 1998, 'Can Antiretroviral Therapy 'treat' Opportunistic Infections in Patients with HIV Infection', HIV Advances in Research and Therapy, 8

Kelleher AD; Roggensack M; Emery S; Carr AD; French MA; Cooper DA, 1998, 'Effects of IL-2 therapy in asymptomatic HIV-infected individuals on proliferative responses to mitogens, recall antigens and HIV-related antigens', Clinical and Experimental Immunology, 113, pp. 85 - 91

Kaufmann GR; Cunningham PH; Kelleher AD; Zaunders J; Carr AD; Vizzard J; Law MG; Cooper DA; Catchpole BR; Baker D; Beveridge A; Bloch M; Byrne J; Doong N; Duncombe CJ; Finlayson R; Genn W; Kidd J; Mcfarlane R; Mcmurchie M; Mcnulty A; Pethebridge A; Quan D; Robertson M, 1998, 'Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection', Journal of Infectious Diseases, 178, pp. 1812 - 1815

Kelleher AD; Roggensack M; Jaramillo AB; Smith DE; Walker AC; Gow I; Mcmurchie M; Harris JA; Patou G; Cooper DA; Duncombe CJ; Bloch M; Quan D; Beveridge A; Genn B; Pethebridge A; Todhunter L; Baker D; Mcfarlane R; Mindel A; Knox J; O Connor C; Mitchell JR; Meese P; Chenworth I; Anderson JS; Roth N, 1998, 'Safety and immunogenicity of a candidate therapeutic vaccine, p24 virus-like particle, combined with zidovudine, in asymptomatic subjects', AIDS, 12, pp. 175 - 182

Kelleher AD; Al-Harthi L; Landay AL, 1997, 'Immunological effects of antiretroviral and immune therapies for HIV.', AIDS London England, 11 Suppl A, pp. S149 - S155

Carr A; Cunningham P; Kelleher A, 1997, 'Diagnosis and treatment of primary HIV infection', J HIV Combination Therapy, pp. 49 - 56

Kelleher A, 1997, 'Restoring Immune Function through Antiretroviral Therapy', Clinical Insight, pp. 1 - 1

Kelleher S; Emery S; Cunningham PH; Duncombe CJ; Carr AD; Golding H; Forde S; Hudson J; Roggensack M; Forrest BD; Cooper DA, 1997, 'Safety and immunogenicity of UBI HIV-1MN octameric V3 peptide vaccine administered by subcutaneous injection', AIDS Research and Human Retroviruses, 13, pp. 29 - 32

Kelleher AD; Smith DE; Cooper DA; Walker A; Gow I; Patou G, 1996, 'Effect of therapeutic vaccination (p24-VLP) and AZT on immunological markers in early HIV disease', AIDS, 10, pp. P137 - P137, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1996VU96300198&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Walker A; Fagan D; Gow I; Kelleher A, 1996, 'The association between CD38 expression on T cells and delayed type hypersensitivity (DTH) response including tuberculin reactivity in asymptomatic HIV seropositive individuals', AIDS, 10, pp. P114 - P114, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1996VU96300177&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kelleher AD; Orth D, 1996, 'Early HIV-induced immune deficiency', Medical Journal of Australia, 164, pp. 107 - 108, http://dx.doi.org/10.5694/j.1326-5377.1996.tb101366.x

Carr A; Emery S; Kelleher A; Law M; Cooper DA, 1996, 'CD8+ lymphocyte responses to antiretroviral therapy of HIV infection', Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 13, pp. 320 - 326, http://dx.doi.org/10.1097/00042560-199612010-00004

Stewart GJ; Irvine SS; Scott M; Kelleher AD; Marriott DJ; McKnight I; Pethebridge AM; Wodak A; Ziegler J, 1996, 'Managing HIV. Part 1: Principles. 1.2 Strategies of care in managing HIV.', Medical Journal of Australia, 164, pp. 99 - 104, http://dx.doi.org/10.5694/j.1326-5377.1996.tb101364.x

Kelleher AD; Carr AD; Zaunders J; Cooper DA, 1996, 'Alterations in the immune response of HIV-infected subjects treated with an HIV specific protease inhibitor, ritonavir', Journal of Infectious Diseases, 173, pp. 321 - 329

Kelleher A, 1996, 'HIV progression and the Immune System: Can HIV Be Eradicated from an Infected Individual', International Medical Press

Kelleher AD; Orth D, 1996, 'Managing HIV:early HIV induced immune deficiency', Medical Journal of Australia, 164, pp. 107 - 108

Kelleher AD; Brew BJ; Milliken ST, 1994, 'Intractable headache as the presenting complaint of AIDS-related lymphoma confined to bone', Journal of Acquired Immune Deficiency Syndromes, 7, pp. 629 - 630

Quinn D; Pocock N; Freund J; Kelleher A; Penny R; Brew B, 1993, 'Radionuclide hepatobiliary scanning in patients with AIDS-related sclerosing cholangitis', Clinical Nuclear Medicine, 18, pp. 417 - 422, http://dx.doi.org/10.1097/00003072-199305000-00010

Kelleher A; Penny R, 1992, 'Immunoglobulin Therapy: Present Status', Present Therapeutics, pp. 39 - 46

Allen TM; Kelleher AD; Zaunders J; Walker BD, 'Structured treatment interruption and beyond', BIOFUTUR, pp. 52 - 58

Back to profile page